Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares 
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 
FDA Approves Mitapivat for Anemia in Thalassemia Patients 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 
Nvidia and Groq Strike Strategic AI Inference Licensing Deal 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy 
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
Dublin, Feb. 17, 2017 -- Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in US$ Thousand by the following Dosage Forms:
- Injectables
- Solid Dosage Forms
- Liquid & Semi-solid Dosage Forms
The report profiles 112 companies including many key and niche players such as
- Aenova Group (Germany)
- Ajinomoto Althea, Inc. (US)
- Albany Molecular Research Inc. (US)
- Alcami Corporation (US)
- Baxter International, Inc. (US)
- Boehringer Ingelheim GmbH (Germany)
- Catalent Pharma Solutions, Inc. (US)
- Cobra Biologics Holding AB (Sweden)
- CordenPharma International (Germany)
- Dishman Group (India)
- DPx Holdings B.V. (US)
- Fareva Group (Luxembourg)
- Famar Health Care Services (Greece)
- Hospira, Inc. (US)
- Jubilant Life Sciences Limited (India)
- Kemwell Biopharma Pvt. Ltd. (India)
- Lonza Group Ltd. (Switzerland)
- LTS Lohmann Therapie-Systeme AG (Germany)
- NextPharma Technologies Holding Ltd. (UK)
- Nipro Pharma Corporation (Japan)
- Recipharm AB (Sweden)
- Vetter Pharma International GmbH (Germany)
Key Topics Covered:
1. Industry Overview
2. Market Trends & Drivers
3. Competitive Landscape
4. Service Overview
5. Recent Industry Activity
6. Focus On Select Players
7. Global Market Perspective
Total Companies Profiled: 112 (including Divisions/Subsidiaries 125)
- The United States (54)
- Canada (2)
- Japan (7)
- Europe (40)
- - France (6)
- - Germany (10)
- - The United Kingdom (7)
- - Italy (3)
- - Spain (2)
- - Rest of Europe (12)
- Asia-Pacific (Excluding Japan) (21)
- Middle East (1)
For more information about this report visit http://www.researchandmarkets.com/research/ptddk8/pharmaceutical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals, Pharmaceutical Manufacturing
